NCT01985568

Brief Summary

The primary aim of this study is to evaluate the extent to which an exercise intervention timed after diet-induced weight loss (rather than initiated at the same time) improves exercise adherence and long-term weight loss. An 18 month randomized trial will be used to compare two behavioral weight loss programs; standard behavioral therapy (Standard BT) and sequential behavioral therapy (Sequential BT). The Standard BT group will receive a traditional behavioral weight loss program where diet and exercise changes are initiated at the same time. The Sequential BT group will receive a program that focuses solely on dietary changes in the initial 6 months, and then incorporates exercise in the ensuing 6 months. Both groups will be followed for 18 months to assess long-term weight loss. The hypothesis is that delivery of diet and exercise interventions in sequence will result in improved adherence to exercise and weight loss at 18 months when compared to a traditional program in which identical diet and exercise interventions are initiated at the same time. This study could identify a strategy that could aid in the development of more effective obesity treatment programs and help more people achieve and sustain a weight loss.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
170

participants targeted

Target at P75+ for not_applicable obesity

Timeline
Completed

Started Nov 2013

Longer than P75 for not_applicable obesity

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 24, 2013

Completed
8 days until next milestone

Study Start

First participant enrolled

November 1, 2013

Completed
14 days until next milestone

First Posted

Study publicly available on registry

November 15, 2013

Completed
4.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2018

Completed
Last Updated

September 28, 2023

Status Verified

September 1, 2023

Enrollment Period

4.8 years

First QC Date

October 24, 2013

Last Update Submit

September 27, 2023

Conditions

Keywords

Obesityweight-lossPhysical activity

Outcome Measures

Primary Outcomes (2)

  • Change in Body Weight

    Body weight will be assessed.

    Baseline, 3, 6, 9, 12, 15, and 18 months.

  • Change in Body Composition

    Body composition will be assessed.

    Baseline, 6, 12, and 18 months.

Secondary Outcomes (6)

  • Objectively Measured Change in Physical Activity

    Baseline, 6, 12, and 18 months.

  • Change in Maximal Aerobic Capacity

    Baseline, 6, 12, and 18 months.

  • Change in Diet Composition

    Baseline, 6, 12, and 18 months.

  • Change in Engagement in Weight Control Eating Behaviors

    Baseline, 6, 12, and 18 months.

  • Change in Dietary Weight Loss Program Attendance and Adherence

    18 months

  • +1 more secondary outcomes

Other Outcomes (12)

  • Change in Number of Exercise Related Injuries and Adverse Events

    18 months

  • Change in Mood

    Baseline, 6, 12, and 18 months.

  • Change in Exercise Self-Efficacy

    Baseline, 6, 12, and 18 months.

  • +9 more other outcomes

Study Arms (2)

Standard Behavioral Therapy (Standard BT)

ACTIVE COMPARATOR

Standard BT: This group will follow a traditional model of initiating exercise concurrently with a dietary intervention for weight loss within an 18 month behavioral weight loss program.

Behavioral: Standard BT

Sequential Behavioral Therapy (Sequential BT)

EXPERIMENTAL

Sequential BT: This group will receive diet and exercise interventions delivered sequentially within an 18 month behavioral weight loss program.

Behavioral: Sequential BT

Interventions

Sequential BTBEHAVIORAL

Both study arms (Standard BT and Sequential BT) will receive an identical 6 month group-based weight loss program, followed by an identical 6 month group-based weight maintenance program, followed by an identical 6 months of weight maintenance phone support. Both groups will also receive an identical 6 month exercise intervention. Groups will differ only in the timing of exercise initiation. Sequential BT will be asked not to begin exercise during months 0-6. They will receive a progressive exercise program and exercise behavior support during months 7-12.

Sequential Behavioral Therapy (Sequential BT)
Standard BTBEHAVIORAL

Both study arms (Standard BT and Sequential BT) will receive an identical 6 month group-based weight loss program, followed by an identical 6 month group-based weight maintenance program, followed by an identical 6 months of weight maintenance phone support. Both groups will also receive an identical 6 month exercise intervention. Groups will differ only in the timing of exercise initiation. Standard BT will begin exercise immediately upon starting the 6 month dietary weight loss intervention. They will receive a progressive exercise program and exercise behavior support during months 0-6.

Standard Behavioral Therapy (Standard BT)

Eligibility Criteria

Age18 Years - 55 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Age 18-55
  • Body Mass Index 27-42 kilograms/meters squared
  • Sedentary: defined as regular exercise of less than 100 minutes per week at moderate intensity or greater during the previous 6 months
  • No self-report of acute or chronic disease (heart disease, diabetes, gastrointestinal disorders and orthopedic problems in particular)
  • No plans to relocate or for extended travel (more than 1 week) within the next 18 months
  • No current tobacco use

You may not qualify if:

  • Live or work within 20 minutes of the University of Colorado Anschutz Health and Wellness Center to ensure reasonable ability to comply with requirement to attend group weight loss sessions and supervised exercise sessions. Exceptions can be made at the discretion of the Study Principal Investigator (PI) on a case by case basis for highly motivated subjects.
  • For Females
  • Not currently pregnant or lactating
  • Not pregnant within the past 6 months
  • Not planning to become pregnant in the next 18 months
  • Sexually active women of childbearing potential may be enrolled if they have had a tubal ligation or use a reliable means of contraception.
  • Presence or history of health problems which would affect appetite, food intake, energy metabolism, or ability to optimally participate in the exercise component including: diabetes, cardiovascular disease, peripheral vascular disease, cerebrovascular disease, uncontrolled hypertension, uncontrolled hyper or hypothyroidism, cancer (within the last 5 years, except skin cancer), human immunodeficiency virus (HIV) infection, significant gastrointestinal, pulmonary, renal, musculoskeletal, neurologic, or hematologic disease
  • Symptoms suggestive of cardiovascular disease: chest pain, shortness of breath at rest or with mild exertion, syncope
  • Abnormal resting electrocardiogram (ECG): serious arrhythmias, including multifocal Premature Ventricular Contractions (PVCs), frequent PVC's (defined as 10 or more per minute), ventricular tachycardia (defined as runs of 3 or more successive PVC's), or sustained atrial tachyarrhythmia; 2nd or 3rd degree A-V block, corrected QT interval \> 480 millisecond or other significant conduction defects
  • Triglycerides \> 400 milligram/deciliter (md/dL) or Low-Density Lipoprotein (LDL) cholesterol \> 190 mg/dL
  • Use of prescription or over-the-counter medications known to affect appetite, weight, heart rate response to exercise, or energy metabolism
  • Use of systemic steroids (other than Oral Contraceptive Pills)
  • Use of obesity pharmacotherapeutic agents within the last 6 months
  • History of surgical procedure for weight loss
  • History of major surgery within the past 3 months
  • +7 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Colorado, Anschutz Health and Wellness Center

Aurora, Colorado, 80045, United States

Location

Related Publications (4)

  • Creasy SA, Ostendorf DM, Kaizer L, Rosenberg R, Breit MJ, Bessesen DH, Melanson EL, Catenacci VA. Effect of physical activity on changes in weight and aerobic capacity during an 18-month behavioral weight loss intervention. Int J Behav Nutr Phys Act. 2025 May 21;22(1):57. doi: 10.1186/s12966-025-01754-3.

  • Creasy SA, Ostendorf DM, Blankenship JM, Grau L, Arbet J, Bessesen DH, Melanson EL, Catenacci VA. Effect of sleep on weight loss and adherence to diet and physical activity recommendations during an 18-month behavioral weight loss intervention. Int J Obes (Lond). 2022 Aug;46(8):1510-1517. doi: 10.1038/s41366-022-01141-z. Epub 2022 May 16.

  • Ostendorf DM, Schmiege SJ, Conroy DE, Phelan S, Bryan AD, Catenacci VA. Motivational profiles and change in physical activity during a weight loss intervention: a secondary data analysis. Int J Behav Nutr Phys Act. 2021 Dec 4;18(1):158. doi: 10.1186/s12966-021-01225-5.

  • Catenacci VA, Ostendorf DM, Pan Z, Bing K, Wayland LT, Seyoum E, Stauffer BL, Phelan S, Creasy SA, Caldwell AE, Wyatt HR, Bessesen DH, Melanson EL. The Impact of Timing of Exercise Initiation on Weight Loss: An 18-Month Randomized Clinical Trial. Obesity (Silver Spring). 2019 Nov;27(11):1828-1838. doi: 10.1002/oby.22624. Epub 2019 Sep 29.

MeSH Terms

Conditions

ObesityWeight LossMotor Activity

Condition Hierarchy (Ancestors)

OverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and SymptomsBody Weight ChangesBehavior

Study Officials

  • Victoria Catenacci, MD

    University of Colorado Anschutz Health and Wellness Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 24, 2013

First Posted

November 15, 2013

Study Start

November 1, 2013

Primary Completion

September 1, 2018

Study Completion

September 1, 2018

Last Updated

September 28, 2023

Record last verified: 2023-09

Data Sharing

IPD Sharing
Will not share

Locations